Simon Daenen

3.6k total citations
78 papers, 2.5k citations indexed

About

Simon Daenen is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, Simon Daenen has authored 78 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 28 papers in Hematology and 17 papers in Epidemiology. Recurrent topics in Simon Daenen's work include Neutropenia and Cancer Infections (24 papers), Acute Myeloid Leukemia Research (17 papers) and Acute Lymphoblastic Leukemia research (12 papers). Simon Daenen is often cited by papers focused on Neutropenia and Cancer Infections (24 papers), Acute Myeloid Leukemia Research (17 papers) and Acute Lymphoblastic Leukemia research (12 papers). Simon Daenen collaborates with scholars based in Netherlands, Belgium and France. Simon Daenen's co-authors include Edo Vellenga, Bob Löwenberg, M. R. Halie, Peter C. Huijgens, Jan J. Cornelissen, Leo F. Verdonck, Harry C. Schouten, Pierre W. Wijermans, Augustin Ferrant and Aloïs Gratwohl and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Simon Daenen

78 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Daenen Netherlands 29 1.0k 695 563 501 484 78 2.5k
Luana Fianchi Italy 28 778 0.8× 565 0.8× 772 1.4× 498 1.0× 264 0.5× 91 2.3k
Jean‐Hugues Dalle France 25 1.1k 1.0× 552 0.8× 492 0.9× 381 0.8× 427 0.9× 154 2.4k
Tsiporah B. Shore United States 27 870 0.8× 919 1.3× 516 0.9× 369 0.7× 188 0.4× 152 2.3k
Tsila Zuckerman Israel 24 945 0.9× 604 0.9× 410 0.7× 425 0.8× 316 0.7× 125 2.5k
T Masaoka Japan 25 1.1k 1.1× 1.1k 1.6× 337 0.6× 854 1.7× 430 0.9× 118 2.7k
Martin Schmidt‐Hieber Germany 26 567 0.6× 629 0.9× 766 1.4× 348 0.7× 102 0.2× 59 2.0k
U. Jehn Germany 24 1.1k 1.0× 827 1.2× 569 1.0× 568 1.1× 451 0.9× 125 2.7k
David Nachbaur Austria 35 2.1k 2.1× 954 1.4× 1.2k 2.1× 752 1.5× 433 0.9× 130 4.4k
Thomas Gastinne France 26 636 0.6× 1.4k 2.0× 305 0.5× 907 1.8× 155 0.3× 127 3.0k
Carlos Solano Spain 35 1.6k 1.6× 1.3k 1.9× 1.8k 3.2× 301 0.6× 349 0.7× 214 4.1k

Countries citing papers authored by Simon Daenen

Since Specialization
Citations

This map shows the geographic impact of Simon Daenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Daenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Daenen more than expected).

Fields of papers citing papers by Simon Daenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Daenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Daenen. The network helps show where Simon Daenen may publish in the future.

Co-authorship network of co-authors of Simon Daenen

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Daenen. A scholar is included among the top collaborators of Simon Daenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Daenen. Simon Daenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaafsma, Martyn Ronald, Peter Joosten, E.F.M. Posthuma, et al.. (2015). Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study. Quality of Life Research. 24(12). 2895–2906. 36 indexed citations
2.
Thielen, Noortje, Bronno van der Holt, Jan J. Cornelissen, et al.. (2013). Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON). European Journal of Cancer. 49(15). 3242–3246. 54 indexed citations
3.
Laaban, J, Simon Daenen, Damien Léger, et al.. (2009). Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes & Metabolism. 35(5). 372–377. 82 indexed citations
4.
Deenik, Wendy, Jeroen J. W. M. Janssen, Bronno van der Holt, et al.. (2009). Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia. Haematologica. 95(6). 914–921. 19 indexed citations
5.
Fátrai, Szabolcs, Hein Schepers, Henko Tadema, et al.. (2008). Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases. Experimental Hematology. 36(10). 1254–1265. 29 indexed citations
6.
7.
Postma, Maarten J., Robin de Vries, Keith Tolley, et al.. (2005). Cost-Effectiveness of Itraconazole for the Prophylaxis of Invasive Fungal Infections for Neutropenic Patients; a Study for 3 European Countries.. Blood. 106(11). 3133–3133. 1 indexed citations
8.
Hovenga, Sjoerd, Simon Daenen, J. Th. M. de Wolf, et al.. (2004). Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study. Annals of Hematology. 84(5). 311–316. 28 indexed citations
9.
Soltner, C., et al.. (2004). Gas embolism: an exceptional complication of radial arterial catheterization. Acta Anaesthesiologica Scandinavica. 48(9). 1208–1210. 14 indexed citations
10.
Löwenberg, Bob, Wim van Putten, Matthias Theobald, et al.. (2003). Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia. New England Journal of Medicine. 349(8). 743–752. 280 indexed citations
11.
Daenen, Simon, et al.. (2001). Alcalose métabolique sévère avec hypokaliémie révélant un syndrome de Cushing paranéoplasique. Annales Françaises d Anesthésie et de Réanimation. 20(10). 860–864. 1 indexed citations
12.
Janknegt, R., et al.. (2000). Antibiotics in granulocytopenic patients with fever. Drug selection by means of the SOJA method.. 3(2). 1 indexed citations
13.
Erjavec, Z., et al.. (1997). Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(5). 364–368. 59 indexed citations
14.
Daenen, Simon, Bob Löwenberg, Pieter Sonneveld, et al.. (1994). Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON).. PubMed. 8(1). 6–10. 26 indexed citations
15.
Donnelly, J. Peter, Georg Maschmeyer, & Simon Daenen. (1992). Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia—ciprofloxacin versus co-trimoxazole plus colistin. European Journal of Cancer. 28(4-5). 873–878. 39 indexed citations
16.
17.
Daenen, Simon, et al.. (1987). An Indonesian Family with the Southeast Asian Type of α-Thalassemia-1 and a γ-Globin Gene Triplication. Acta Haematologica. 78(1). 23–27. 2 indexed citations
18.
Meer, J. van der, et al.. (1986). Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.. BMJ. 292(6527). 1049–1049. 11 indexed citations
19.
Daenen, Simon, et al.. (1986). Effect of Intestinal Flora Modulation by Oral Polymyxin Treatment on Hemopoietic Stem Cell sKinetics in Mice. Acta Haematologica. 76(1). 44–49. 14 indexed citations
20.
Daenen, Simon, R.A. Rojer, Johannes W. A. Smit, M. R. Halie, & H. O. Nieweg. (1984). Successful chemotherapy with deoxycoformycin in adult T‐cell lymphoma‐leukaemia. British Journal of Haematology. 58(4). 723–727. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luana Fianchi Breakdown of academic impact, for papers by Jean‐Hugues Dalle Breakdown of academic impact, for papers by Tsiporah B. Shore Breakdown of academic impact, for papers by Tsila Zuckerman Breakdown of academic impact, for papers by T Masaoka Breakdown of academic impact, for papers by Martin Schmidt‐Hieber Breakdown of academic impact, for papers by U. Jehn Breakdown of academic impact, for papers by David Nachbaur Breakdown of academic impact, for papers by Thomas Gastinne Breakdown of academic impact, for papers by Carlos Solano
Rankless by CCL
2026